Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sinovac Biotech Ltd.

www.sinovac.com

Latest From Sinovac Biotech Ltd.

A Shocking Shot: China's Latest Vaccine Forgery More Problematic Than Ever

Just when a fragile sector has barely regained its footing, a new vaccine scandal in China has and come into the national spotlight, and some underlying issues this time could go beyond distribution negligence and regulatory non-compliance.

China Drug Safety

Pipeline Watch: Phase III Progress With Esaxerenone, Lusutrombopag

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Deals Shaping The Medical Industry, July 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2017.

Deals BioPharmaceutical

Deal Watch: Entasis, GARDP Partner On Novel Antibiotic For Drug-Resistant Gonorrhea

Servier and Transgene will collaborate to apply viral vector technology to the development of CAR-T therapeutics, while Chinese vaccine maker Sinovac is taken private by an investment consortium.

Deals M & A
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Net Force Systems Inc.
  • Sinovac Biotech Co. Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Sinovac Biotech Ltd.
  • Senior Management
  • Weidong Yin, Chmn., Pres. & CEO
    Nan Wang, CFO & VP. Bus. Dev.
    Ming Xia, VP, Sales & Mktg.
  • Contact Info
  • Sinovac Biotech Ltd.
    Phone: (86) 10-82890088
    39 Shangdi Xi Rd., Haidian District
    Beijing, 100085
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register